Study assesses use of erythropoiesis-stimulating agents

05/16/2013 | Reuters

A study in JAMA Internal Medicine examined the use of erythropoiesis-stimulating agents after a 2007 FDA black box warning urged facilities to limit their use because of side effects. The study analyzed data involving 275,291 patients.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX